| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00216-013-7199-0 |
| P698 | PubMed publication ID | 23900670 |
| P50 | author | Pierre Lanteri | Q56986203 |
| P2093 | author name string | Francoise Lasne | |
| Claire Bordes | |||
| Cécile Cren-Olivé | |||
| Corinne Buisson | |||
| Agneta Kiss | |||
| P2860 | cites work | Proposed minimum reporting standards for chemical analysis | Q27921801 |
| Gas chromatography/mass spectrometry in metabolic profiling of biological fluids | Q30843536 | ||
| Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). | Q30966021 | ||
| Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis | Q31032346 | ||
| Scaling and normalization effects in NMR spectroscopic metabonomic data sets | Q31035575 | ||
| Centering, scaling, and transformations: improving the biological information content of metabolomics data | Q31043704 | ||
| Analytical strategies in metabonomics | Q31097049 | ||
| Mass spectrometry-based metabolomics | Q33254576 | ||
| Mass spectrometry for the identification of the discriminating signals from metabolomics: current status and future trends | Q33440434 | ||
| Within-day reproducibility of an HPLC-MS-based method for metabonomic analysis: application to human urine | Q34649328 | ||
| Metabolome-wide association study identifies multiple biomarkers that discriminate north and south Chinese populations at differing risks of cardiovascular disease: INTERMAP study | Q35051204 | ||
| Metabonomics techniques and applications to pharmaceutical research & development | Q36484646 | ||
| Beyond blood sugar: the potential of NMR-based metabonomics for type 2 human diabetes, and the horse as a possible model | Q36666488 | ||
| Metabonomics in pharmaceutical discovery and development. | Q36725146 | ||
| LC-MS-based metabonomics analysis | Q36993639 | ||
| New technologies around biomarkers and their interplay with drug development | Q36995206 | ||
| Advances in separation science applied to metabonomics | Q37292558 | ||
| From differentiating metabolites to biomarkers | Q37412408 | ||
| Metabolomics: moving to the clinic | Q37462435 | ||
| Metabolomics in toxicology: preclinical and clinical applications | Q37815356 | ||
| Serum metabolomics as a novel diagnostic approach for disease: a systematic review | Q38014695 | ||
| Tools in metabonomics: an integrated validation approach for LC-MS metabolic profiling of mercapturic acids in human urine | Q40240381 | ||
| 1H NMR-based metabonomic analysis of metabolic changes in streptozotocin-induced diabetic rats | Q42778896 | ||
| Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves | Q43071178 | ||
| Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. | Q43284301 | ||
| Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics | Q43410367 | ||
| Neuronal metabolomics by ion mobility mass spectrometry: cocaine effects on glucose and selected biogenic amine metabolites in the frontal cortex, striatum, and thalamus of the rat. | Q43553717 | ||
| UPLC-TOF-MS for plant metabolomics: a sequential approach for wound marker analysis in Arabidopsis thaliana | Q44986764 | ||
| Orthogonal projections to latent structures discriminant analysis modeling on in situ FT-IR spectral imaging of liver tissue for identifying sources of variability | Q46420881 | ||
| Development and validation of a ultra performance LC-ESI/MS method for analysis of metabolic phenotypes of healthy men in day and night urine samples | Q46435789 | ||
| Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms. | Q51676484 | ||
| Liquid chromatography and ultra-performance liquid chromatography-mass spectrometry fingerprinting of human urine: sample stability under different handling and storage conditions for metabonomics studies. | Q53554788 | ||
| A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis. | Q53588029 | ||
| Orthogonal projections to latent structures (O-PLS) | Q56435041 | ||
| Validation of a urine metabolome fingerprint in dog for phenotypic classification | Q57803458 | ||
| The evolution of partial least squares models and related chemometric approaches in metabonomics and metabolic phenotyping | Q58045688 | ||
| Generation of Ultrahigh Peak Capacity LC Separations via Elevated Temperatures and High Linear Mobile-Phase Velocities | Q58045904 | ||
| NMR-based metabonomic toxicity classification: hierarchical cluster analysis and k-nearest-neighbour approaches | Q58046056 | ||
| Development of analytical methods for NMR spectra and application to a 13C toxicology study | Q58051312 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tetrahydrocannabinol | Q190067 |
| cannabinoids | Q422936 | ||
| P304 | page(s) | 1209-1219 | |
| P577 | publication date | 2013-07-31 | |
| P1433 | published in | Analytical and Bioanalytical Chemistry | Q2845280 |
| P1476 | title | Data-handling strategies for metabonomic studies: example of the UHPLC-ESI/ToF urinary signature of tetrahydrocannabinol in humans | |
| P478 | volume | 406 |
| Q38371837 | A short review of applications of liquid chromatography mass spectrometry based metabolomics techniques to the analysis of human urine |
| Q58579004 | Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications |
| Q86417590 | Annual banned-substance review: analytical approaches in human sports drug testing |
| Q47420831 | Chemometric and high-resolution mass spectrometry tools for the characterization and comparison of raw and treated wastewater samples of a pilot plant on the SIPIBEL site |
| Q87444829 | Comparative analysis of volatile oils in the stems and roots of Ephedra sinica via GC-MS-based plant metabolomics |
Search more.